Biology of muscle impairment in COPD

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 59, Issue 4, 2003, Pages 338-341

  Maltais, François ^a   Debigare R ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; PRASTERONE SULFATE; PROTEASOME; PROTEASOME INHIBITOR; SOMATOMEDIN C; TUMOR NECROSIS FACTOR; UBIQUITIN;

ARTICLE; BIOCHEMISTRY; BIOSYNTHESIS; CACHEXIA; CATABOLISM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DIET THERAPY; DISEASE SEVERITY; EXERCISE; EXERCISE TOLERANCE; HUMAN; MEDICAL RESEARCH; MORTALITY; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE WEAKNESS; NUTRITIONAL STATUS; OXIDATIVE STRESS; PROGNOSIS; PROTEIN DEGRADATION; SURVIVAL; WEIGHT REDUCTION; DISEASE COURSE; FEMALE; HOSPITALIZATION; MALE; MUSCLE FATIGUE; MUSCULOSKELETAL DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK ASSESSMENT; SKELETAL MUSCLE; WASTING SYNDROME;

DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MUSCLE FATIGUE; MUSCLE, SKELETAL; MUSCULOSKELETAL DISEASES; OXIDATIVE STRESS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; WASTING SYNDROME;

EID: 2942511374     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 152: 2021-2031.
2. Simpson K, Killian K, McCartney N, Stubbing DG, Jones NL. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax 1992; 47: 70-75.
3. Schols AMWJ, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-1797.
4. Schols AMWJ, Soeters PB, Dingemans MC, Mostert R, Frantzen PJ, Wouters EFM. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147: 1151-1156.
5. Bernard S, Leblanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 629-634.
6. Engelen MPKJ, Schols AMWJ, Baken WC, Wesseling GJ, Wouters EFM. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 1994; 7: 1793-1797.
7. Schols AMWJ, Mostert R, Soeters PB, Wouters EFM. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 1991; 46: 695-699.
8. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139: 1435-1438.
9. Marquis K, Debigaré R, LeBlanc P, Lacasse Y, Jobin J, Carrier G, Maltais F. Mid-thigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with COPD. Am J Respir Crit Care Med 2002; 166: 809-813.
10. Lewis MI, Belman MJ, Dorr-Uyemura L. Dietary supplementation and respiratory muscle performance in patients with COPD. Am Rev Respir Dis 1987; 135: 1062-1068.
11. Knowles JB, Fairbarn MS, Wiggs BJ, Chan-Yan C, Pardy RL. Dietary supplementation and respiratory muscle performance in patients with COPD. Chest 1988; 93: 977-983.
12. Whittaker JS, Ryan CF, Buckley PA, Road JD. The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients. Am Rev Respir Dis 1990; 142: 283-288.
13. Donahoe M, Mancino J, Lebow H, Rogers RM. The effect of an aggressive nutritional support regimen on body composition in patients with severe COPD and weight loss. Am J Respir Crit Care Med 1994; 149: A313.
14. Debigaré R, Côté CH, Maltais F. Peripheral muscle wasting in COPD: clinical relevance and mechanisms. Am J Respir Crit Care Med 2001; 164: 1712-1717.
15. Tisdale MJ. Biology of cachexia. J Natl Cancer Inst 1997; 89: 1763-1773.
16. Kotler DP. Cachexia. Ann Intern Med 2000; 133: 622-634.
17. Mitch WE, Goldberg AL. Mechanism of muscle wasting. N Engl J Med 1996; 335: 1897-1905.
18. Llovera M, Garcia-Martinez C, Lopez-Soriano J, Carbo N, Agell N, Lopez-Soriano FJ, Argiles JM. Role of TNF receptor I in prtein turnover during cancer cachexia using gene knockout mice. Mol Cell Endocrinol 1998; 142: 183-189.
19. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 1996; 97: 1447-1453.
20. Niebauer J, Pflaum CD, Clark AL, Strasburger CJ, Hooper J, Poole-Wilson PA, Coats AJ, Anker SD. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 1998; 32: 393-397.
21. Price SR, Baily JL, Wang X, Jurkovitz C, England BK, Ding X, Phillips LS, Mitch WE. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, Ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest 1996; 98: 1703-1708.
22. Tisdale MJ. Wasting in cancer. J Nutr 1999; 129: 243S-246S.
23. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82: 373-428.
24. Hasselgren P-O, Fischer JE. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Annals of surgery 2001; 233: 9-17.
25. Mitch WE, Baily JL, Wang X, Jurkovitz C, Newby D, Price SR. Evaluation of signals activating ubiquiti-proteasome proteolysis in a model of muscle wasting. Am J Physiol 1999: 276: C1132-C1138.
26. Li YP, Reid MB. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol 2000; 279: R1165-R1170.
27. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin Jr AS. NF-kB - induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000; 289: 2363-2366.
28. Buck M, Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. Embo J 1996; 15: 1753-1765.
29. Ceconi C, Curello S, Bachetti T, Corti A, Ferrari R. Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? Prog Cardiovasc Dis 1998; 41: 25-30.
30. Rauchhaus M, Koloczck V, Volk H-D, Kemp M, Niebauer J, Francis DP, Coats AJS, Anker SD. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. International Journal of Cardiology 2000; 76: 125-133.
31. Moldawer LL, Sattler FR. Human immunodeficiency virus-associated wasting and mechanism of cachexia associated with inflammation. Semin Oncol 1998; 25 (suppl 1):73-81.
32. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 1453-1455.
33. Schols AMWJ, Buurman WA, Staal-van den Brekel AJ, Dentener MA, Wouters EFM. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 819-824.
34. Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, Saito H, Yuki H, Kato S, Tomoike H. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-α system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1179-1184.
35. Eid AA, Ionescu AA, Nixon LS, Lewis-Jenkins V, Mathews SB, Griffiths TL, Shale DJ. The inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1414-1418.
36. Creutzberg EC, Schols AMWJ, Weling-Scheepers CAPM, Buurman WA, Wouters EF. Characterization of nonresponse to high caloric oral nutrition therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 745-752.
37. Debigaré R, Marquis K, Côté CH, Tremblay RR, Michaud A, LeBlanc P, Maltais F. Catabolic/anabolic balance and muscle wasting in patients with chronic obstructive pulmonary disease. Chest 2003; 124: 83-89.
38. Casaburi R, Goren S, Bhasin S. Substantial prevalence of low anabolic hormone levels in COPD patients undergoing rehabilitation. American Journal of Respiratory and Critical Care Medicine 1996; 153: A128.
39. Ostrowski K, Rohde T, Zacho M, Asp S, Pedersen BK. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 1998; 508: 949-953.
40. Malm C, Nyberg P, Engstrom M, Sjodin B, Lenkei R, Ekblom B, Lundberg I. Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies. J Physiol 2000; 529 Pt 1: 243-262.
41. Reid MB. COPD as a muscle disease. Am J Respir Crit Care Med 2001; 164: 1101-1102.
42. Heunks LM, Viña J, van Herwaarden CLA, Folgering HTM, Gimeno A, Dekhuijzen PNR. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol 1999; 277: R1697-R1704.
43. Langen RC, Schols AM, Kelders MC, Van Der Velden JL, Wouters EF, Janssen-Heininger YM. Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol 2002; 283: C714-C721.
44. Couillard A, Maltais F, Saey D, Debigaré R, Michaud A, Koechlin C, LeBlanc P, Préfaut C. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with COPD. Am J Respir Crit Care Med 2003; 167: 1664-1669.
45. Bernard S, Whittom F, Leblanc P, Jobin J, Belleau R, Bérubé C, Carrier G, Maltais F. Aerobic and strength training in patients with COPD. Am J Respir Crit Care Med 1999; 159: 896-901.
46. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2002; 2: 862-871.